Cargando…

Changes in Sexual Function in Benign Prostatic Hyperplasia Patients Taking Dutasteride: 1-Year Follow-Up Results

PURPOSE: Sexual adverse events (AEs), a major cause for discontinuing 5α-reductase inhibitor (5ARI) therapy for benign prostatic hyperplasia (BPH), are known to occur most frequently early in therapy and appear to decline over time. The aim of this study was to investigate the changes in sexual func...

Descripción completa

Detalles Bibliográficos
Autores principales: Chi, Byung Hoon, Kim, Sae Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198238/
https://www.ncbi.nlm.nih.gov/pubmed/22025960
http://dx.doi.org/10.4111/kju.2011.52.9.632